Table 2.
Characteristics of patients from transplant haematology ward infected with CoNS displaying reduced susceptibility to glycopeptides
| Pat. | Age | Underlying disease | Antimicrobial prophylaxis | Neutrophyl count/mm3 | Days from transplantation | Immuno-suppression | Therapy | Catheter removal | CR-BSI | Micro-biological eradication |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 29 | ALL | no | 2300 | 43 | ciclosporin | linezolid-pip/tazo-amika | no | ? | yes |
| 2 | 40 | MM | no | 1380 | 128 | ciclosporin | teicoplanin-pip/tazo-amika | no | ? | yes |
| 3 | 34 | AML | levofloxacin | 10 | 9 | no | linezolid-pip/tazo-amika | yes | yes | yes |
| 4 | 20 | HD | no | 6200 | 3 | no | teicoplanin-pip/tazo-amika | no | ? | yes |
| 5 | 52 | NHL | levofloxacin | 10 | 5 | no | teicoplanin-pip/tazo-amika | yes | yes | yes |
| 6 | 54 | ALL | no | 1000 | 3 | ciclosporin | teicoplanin | yes | yes | yes |
| 7 | 58 | MM | no | 3700 | 30 | no | teicoplanin-pip/tazo-amika | yes | yes | yes |
ALL = acute lymphocitic leukaemia; AML = acute myeloid leukaemia; MM = multiple myeloma; HD = Hodgkin's disease; NHL = non-Hodgkin's lymphoma; MUD = matched unrelated donor; pip/tazo = piperacillin/tazobactam; amika = amikacin; CR-BSI = catheter related blood stream infection; ? = not confirmed